The C8 Sciences™ Science Advisory Board

The C8 Sciences™ Science Advisory Board plays a critical role in the continuous and rigorous scientific evaluation of how well our programs are performing. C8 Sciences™ has constituted a small working board of internationally recognized scientific leaders in child cognitive development, childhood developmental problems like ADHD, and assessment and improvement of cognitive function. Each member of the Board has deep interest in the C8 Sciences™ mission and the committee actively directs the analysis of program performance and the degree of benefit children derive from using the programs.

Morris Bell, PhD

Morris Bell, PhD, is Professor in the Department of Psychiatry at Yale University School of Medicine and Senior Research Career Scientist for the Dept. of Veterans Affairs Rehabilitation Research and Development Service.

Trained as a clinical and neuropsychologist, Dr. Bell’s career as clinician and researcher has been devoted to exploring interventions to restore cognitive and work function for people with severe and persistent mental disorders. His work spans three decades and has had wide national and international influence. Dr. Bell’s research has been at the forefront of developing cognitive remediation interventions to improve vocational outcomes in work therapy and supported employment. His current studies are funded by the National Institute of Mental Health, National Institute of Drug Abuse, the Department of Defense and the Department of Veterans Affairs. Dr. Bell has developed a number of psychological instruments related to social cognition and social functioning including the Bell Object Relations Reality Testing Inventory (BORRTI) and the Bell Relationship Inventory for Adolescents (BRIA), both published by Western Psychological Services, and the Bell Lysaker Emotion Recognition Test, the Social Attribution Test – Multiple Choice, and the American version of the Hinting Task. Other tests he co-developed include the Work Behavior Inventory and the Vocational Cognitive Rating Scale. He is currently involved in developing a virtual reality, simulated job interview role-playing program to help patients prepare for job interviews.

James F. Leckman, MD

James F. Leckman, MD, is the Neison Harris Professor of Child Psychiatry, Psychiatry, Psychology and Pediatrics at Yale University. Dr. Leckman, a well-known child psychiatrist and patient-oriented clinical investigator, has been selected by his peers as one of the “Best Doctors in America”.

He is also one of the most cited published research authors on Psychology and Psychiatry in the world. Dr. Leckman is widely recognized as a committed clinician with special skills in the evaluation and treatment of ADHD, Tourette syndrome, and early onset obsessive-compulsive disorder. He is committed to evaluating novel treatments, including behavioral and other types of interventions and stimulation to enhance neurocognitive abilities. Over the past 30 years, he has seen and evaluated hundreds of individuals with these conditions. Physicians, patients and families from across the country and around the world regularly seek his advice. He is frequently invited to address professional, parent and advocacy groups at local, regional, national and international meetings. During the past decade, he has presented to professional and family groups in London, Rotterdam, Barcelona, Berlin, Rome, Florence, Johannesburg, Istanbul, Ankara, Beirut, Cairo, Alexandria, Sharm El Sheikh, Tehran, Tel Aviv, Beijing, Taipei, Tokyo, Mexico City, Lima, Santiago, and Sao Paulo.

Sarah Shizuko Morimoto, PsyD

Sarah Shizuko Morimoto, PsyD is Assistant Professor in the Department of Psychiatry at Weill Cornell Medical College. Dr. Morimoto is a trained clinical neuropsychologist focused on the integration of both neurocognitive and psychological testing for accurate diagnosis of psychiatric and neurological conditions in children, adults and older adults.

Dr. Morimoto’s research specialization is in the use of multiple neurobiological measures (EEG, fMRI and MRI, genetics and neurocognitive testing) to identify key, clinically relevant, abnormalities in neural circuits that predispose patients to poor treatment outcomes. For example, she has identified a singular cognitive deficit that predicts non-remission of geriatric depression with conventional antidepressants, regardless of the task by which it is elicited. This work was internationally recognized with a Junior Investigator award by the International College of Geriatric Psychoneuropharmacology. Based on these findings, Dr. Morimoto and Dr. Wexler are developing a computerized cognitive remediation intervention (CCR-GD) targeted to treat these cognitive deficits. The goal of the treatment is to target and change the underlying neural circuit dysfunction that predisposes patients to non-remission. The computer programs are based on the principles of neuroplasticity in the aging brain and are designed to treat both cognitive and affective symptoms of the disorder. Dr. Morimoto’s research, focused on geriatric depression, is funded by both the National Institute of Mental Health, and the Clinical Translational Science Center.

David Rabiner, PhD

David Rabiner, PhD, is a Research Professor at Duke University where he serves as the Director of Undergraduate Studies in the Department of Psychology & Neuroscience and as an Associate Director of the Center for Child and Family Policy.

Dr. Rabiner received his PhD in clinical psychology from Duke in 1987 and was a professor in the Department of Psychology at UNC-Greensboro until 1999 when he returned to Duke.  He has published nearly 50 scientific articles on issues that include children’s peer relations, social cognition, and aggressive behavior, ADHD, attention problems, and new interventions for attention difficulties. Since 2000, Dr. Rabiner has been Principal Investigator or Co-Investigator on 7 federal grants totaling over $10M, 5 of which focused specifically on ADHD, attention difficulties, and cognitive training for attention difficulties. He is a former member of the Professional Advisory Board of CHADD, the national support organization for children and adults with ADHD and serves on the Social and Behavioral Grant Review Panel for the Institute of Education Sciences. Dr. Rabiner is also the founder of Attention Research Update, an online newsletter that helps over 40,000 subscribers keep up with the latest research on ADHD.

Philip David Zelazo, PhD

Philip David Zelazo, PhD, is currently the Nancy M. and John E. Lindahl Professor at the Institute of Child Development, University of Minnesota, and the Co-Director of the Sino-Canadian Centre for Research in Child Development, at Southwest University, China.

From 1992-2007, he taught at the University of Toronto, where he held the Canada Research Chair in Developmental Neuroscience. Professor Zelazo’s research on the development and neural bases of executive function (the control of thought, action, and emotion) has been honored by numerous awards, including a Boyd McCandless Young Scientist Award from the American Psychological Association (APA), and a Canada’s Top 40 Under 40 Award. He is a Fellow of the APA, the American Psychological Society (APS), and the Mind and Life Institute. He is also President of the Jean Piaget Society, a member of the Advisory Board of the Baumann Institute, and a member of several editorial boards (e.g., Child Development; Emotion, Frontiers in Human Neuroscience; Development and Psychopathology; Monographs of the SRCD, Developmental Cognitive Neuroscience). Professor Zelazo is Associate Editor of Child Development Perspectives, co-editor of The Cambridge Handbook of Consciousness (Zelazo, Moscovitch, & Thompson, 2007), and editor of the forthcoming Oxford Handbook of Developmental Psychology.

Read more about the science behind C8 Sciences.